2 months ago
AMRX
AnalystsDaniel ClarkDaniel Clark's Stock Forecasts
AnalystsDaniel Clark
Analyst Ranking
Top 33%
#1809 out of 5550 analysts
Average Return
+14.67%
Win Rate
75%9 out of 12
Risk vs Reward
Poor
Good
Daniel Clark's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Elanco Animal Health IncELAN | +73.46% | $14.96 | $25.95 | 2025-07-17 - 2026-07-16 | Buy |
Idexx Laboratories IncIDXX | +69.22% | $430.77 | $728.97 | 2024-12-02 - 2025-12-01 | Buy |
Amneal Pharmaceuticals IncAMRX | +24.70% | $17.25 | $21.51 | 2026-09-09 - 2026-10-30 | Buy |
Viatris IncVTRS | +15.36% | $16.50 | $19.04 | 2026-09-09 - 2026-10-30 | Buy |
Teva Pharmaceutical Industries LtdTEVA | +14.22% | $36.85 | $42.09 | 2026-09-09 - 2026-10-30 | Buy |
Daniel Clark Analyst Color
Get additional color on Daniel Clark's coverage of popular stocks
Daniel Clark's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viatris IncVTRS | 1 | Buy | $20.00 | +5.07% | Initiates Coverage On | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Buy | $45.00 | +6.91% | Initiates Coverage On | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 1 | Hold | $10.00 | +74.22% | Initiates Coverage On | 2 months ago |
Pacira Biosciences IncPCRX | 1 | Hold | $28.00 | -23.06% | Initiates Coverage On | 2 months ago |
Harrow IncHROW | 1 | Buy | $45.00 | +59.35% | Initiates Coverage On | 2 months ago |
Collegium Pharmaceutical IncCOLL | 1 | Buy | $45.00 | +89.08% | Initiates Coverage On | 2 months ago |
Bausch & Lomb CorpBLCO | 1 | Buy | $24.00 | +20.00% | Initiates Coverage On | 2 months ago |
Amneal Pharmaceuticals IncAMRX | 1 | Buy | $23.00 | +6.93% | Initiates Coverage On | 2 months ago |
Elanco Animal Health IncELAN | 3 | Buy | $30.00 | +30.10% | Maintains | 8 months ago |
Idexx Laboratories IncIDXX | 3 | Buy | $600.00 | N/A | Maintains | a year ago |
Zoetis IncZTS | 2 | Hold | $155.00 | N/A | Downgrades | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.